COPD and microalbuminuria: a 12-year follow-up study
S Romundstad, T Naustdal… - European …, 2014 - Eur Respiratory Soc
S Romundstad, T Naustdal, PR Romundstad, H Sorger, A Langhammer
European Respiratory Journal, 2014•Eur Respiratory SocChronic obstructive pulmonary disease (COPD), low lung function independent of diagnosis
and markers of inflammation are all associated with increased morbidity and mortality.
Microalbuminuria, reflecting endothelial dysfunction, could be a relevant inflammatory
marker of potential systemic effects of COPD. We hypothesised that there was a positive
association between microalbuminuria and mortality in individuals with COPD. We
conducted a 12-year follow-up study of 3129 participants in the second survey of the Nord …
and markers of inflammation are all associated with increased morbidity and mortality.
Microalbuminuria, reflecting endothelial dysfunction, could be a relevant inflammatory
marker of potential systemic effects of COPD. We hypothesised that there was a positive
association between microalbuminuria and mortality in individuals with COPD. We
conducted a 12-year follow-up study of 3129 participants in the second survey of the Nord …
Chronic obstructive pulmonary disease (COPD), low lung function independent of diagnosis and markers of inflammation are all associated with increased morbidity and mortality. Microalbuminuria, reflecting endothelial dysfunction, could be a relevant inflammatory marker of potential systemic effects of COPD. We hypothesised that there was a positive association between microalbuminuria and mortality in individuals with COPD.
We conducted a 12-year follow-up study of 3129 participants in the second survey of the Nord-Trøndelag Health Study (HUNT), Norway. At baseline, albuminuria was analysed in three urine samples and spirometry was performed. Among the participants, 136 had COPD and microalbuminuria, defined as a urinary albumin/creatinine ratio between 2.5 and 30.0 mg·mmol−1. The main outcome measures were hazard ratio of all-cause mortality according to microalbuminuria.
Compared to those with COPD without microalbuminuria, the adjusted hazard ratio for all-cause mortality in those with COPD and microalbuminuria was 1.54, 95% CI 1.16–2.04. This result was similar after excluding cardiovascular disease at baseline. Classifying COPD severity by Global Initiative for Chronic Obstructive Lung Disease, there was a positive association trend with increasing severity stages.
Microalbuminuria is associated with all-cause mortality in individuals with COPD and could be a relevant tool in identification of patients with poor prognosis.
European Respiratory Society